{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:13:25Z","timestamp":1793330005469,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","award":["BX004594"],"award-info":[{"award-number":["BX004594"]}],"id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014923","name":"CymaBay Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["BX004594"],"award-info":[{"award-number":["BX004594"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AA020703"],"award-info":[{"award-number":["R01 AA020703"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AA026939"],"award-info":[{"award-number":["U01 AA026939"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AA24726"],"award-info":[{"award-number":["R01 AA24726"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jhepr.2020.100220","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T21:39:40Z","timestamp":1607636380000},"page":"100220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["Gut dysbiosis as a driver in alcohol-induced liver injury"],"prefix":"10.1016","volume":"3","author":[{"given":"Bradley","family":"Fairfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Schnabl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jhepr.2020.100220_bib1","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1136\/gutjnl-2018-316723","article-title":"Human gut microbiome: hopes, threats and promises","volume":"67","author":"Cani","year":"2018","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100220_bib2","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/0884533615609899","article-title":"Gut microbiome: what we do and don't know","volume":"30","author":"Cresci","year":"2015","journal-title":"Nutr Clin Pract"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100220_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-017-1445-8","article-title":"Gut microbiota functions: metabolism of nutrients and other food components","volume":"57","author":"Rowland","year":"2018","journal-title":"Eur J Nutr"},{"issue":"7","key":"10.1016\/j.jhepr.2020.100220_bib4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.jhepr.2020.100220_bib5","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"issue":"7122","key":"10.1016\/j.jhepr.2020.100220_bib6","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100220_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/1574887111666160810101202","article-title":"Epidemiology and natural history of alcoholic liver disease","volume":"11","author":"Masarone","year":"2016","journal-title":"Rev Recent Clin Trials"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100220_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG clinical guideline: alcoholic liver disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100220_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.35946\/arcr.v38.2.01","article-title":"Alcoholic liver disease: pathogenesis and current management","volume":"38","author":"Osna","year":"2017","journal-title":"Alcohol Res"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100220_bib10","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","article-title":"Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease","volume":"65","author":"Llopis","year":"2016","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100220_bib11","first-page":"30","article-title":"Jejunal microflora in patients with chronic alcohol abuse","volume":"31","author":"Bode","year":"1984","journal-title":"Hepatogastroenterology"},{"issue":"9","key":"10.1016\/j.jhepr.2020.100220_bib12","doi-asserted-by":"crossref","first-page":"G966","DOI":"10.1152\/ajpgi.00380.2011","article-title":"Colonic microbiome is altered in alcoholism","volume":"302","author":"Mutlu","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100220_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s40168-017-0359-2","article-title":"Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease","volume":"5","author":"Dubinkina","year":"2017","journal-title":"Microbiome"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100220_bib14","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.24423","article-title":"Characterization of fecal microbial communities in patients with liver cirrhosis","volume":"54","author":"Chen","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100220_bib15","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","article-title":"Modulation of the fecal bile acid profile by gut microbiota in cirrhosis","volume":"58","author":"Kakiyama","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100220_bib16","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2020.100220_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/liv.14383","article-title":"Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease","author":"Addolorato","year":"2020","journal-title":"Liver Int"},{"issue":"11","key":"10.1016\/j.jhepr.2020.100220_bib18","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/acer.13498","article-title":"Continued alcohol misuse in human cirrhosis is associated with an impaired gut-liver Axis","volume":"41","author":"Bajaj","year":"2017","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100220_bib19","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1038\/s41598-018-23146-3","article-title":"Characterization of intestinal microbiota in alcoholic patients with and without alcoholic hepatitis or chronic alcoholic pancreatitis","volume":"8","author":"Ciocan","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2020.100220_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31178","article-title":"Fecal microbiome distinguishes alcohol consumption from alcoholic hepatitis but does not discriminate disease severity","author":"Smirnova","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100220_bib21","first-page":"1","article-title":"Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients","author":"Lang","year":"2020","journal-title":"Gut Microbes"},{"issue":"5","key":"10.1016\/j.jhepr.2020.100220_bib22","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","article-title":"Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease","volume":"67","author":"Grander","year":"2018","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.jhepr.2020.100220_bib23","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1172\/JCI90562","article-title":"Intestinal fungi contribute to development of alcoholic liver disease","volume":"127","author":"Yang","year":"2017","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100220_bib24","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.30832","article-title":"Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis","volume":"71","author":"Lang","year":"2020","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100220_bib25","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1136\/gutjnl-2016-313170","article-title":"Fungal dysbiosis in cirrhosis","volume":"67","author":"Bajaj","year":"2018","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100220_bib26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.chom.2019.09.009","article-title":"The human gut virome is highly diverse, stable, and individual specific","volume":"26","author":"Shkoporov","year":"2019","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100220_bib27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2015.01.002","article-title":"Disease-specific alterations in the enteric virome in inflammatory bowel disease","volume":"160","author":"Norman","year":"2015","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100220_bib28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1053\/j.gastro.2018.04.018","article-title":"Alterations in enteric virome are associated with colorectal cancer and survival outcomes","volume":"155","author":"Nakatsu","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2020.100220_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31459","article-title":"Intestinal virome in patients with alcoholic hepatitis","author":"Jiang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100220_bib30","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.07.005","article-title":"Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease","author":"Lang","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2020.100220_bib31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.biochi.2015.05.014","article-title":"Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice","volume":"115","author":"Wu","year":"2015","journal-title":"Biochimie"},{"issue":"2","key":"10.1016\/j.jhepr.2020.100220_bib32","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2018.03.031","article-title":"Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis","volume":"69","author":"Brandl","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.jhepr.2020.100220_bib33","doi-asserted-by":"crossref","first-page":"G929","DOI":"10.1152\/ajpgi.00315.2013","article-title":"Colonic inflammation and secondary bile acids in alcoholic cirrhosis","volume":"306","author":"Kakiyama","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"19","key":"10.1016\/j.jhepr.2020.100220_bib34","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199405123301903","article-title":"Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group","volume":"330","author":"Poupon","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"7783","key":"10.1016\/j.jhepr.2020.100220_bib35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100220_bib36","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jhep.2019.09.029","article-title":"The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease","volume":"72","author":"Chu","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100220_bib37","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/hep.29623","article-title":"The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis","volume":"67","author":"Puri","year":"2018","journal-title":"Hepatology"},{"issue":"42","key":"10.1016\/j.jhepr.2020.100220_bib38","doi-asserted-by":"crossref","first-page":"E4485","DOI":"10.1073\/pnas.1415174111","article-title":"Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity","volume":"111","author":"Leclercq","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jhepr.2020.100220_bib39","doi-asserted-by":"crossref","first-page":"1782157","DOI":"10.1080\/19490976.2020.1782157","article-title":"Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans","volume":"12","author":"Maccioni","year":"2020","journal-title":"Gut Microbes"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100220_bib40","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ijo.2016.23","article-title":"Reprogramming of hepatic fat accumulation and 'browning' of adipose tissue by the short-chain fatty acid acetate","volume":"40","author":"Sahuri-Arisoylu","year":"2016","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100220_bib41","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1053\/j.gastro.2014.08.031","article-title":"Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial","volume":"147","author":"Dhiman","year":"2014","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.jhepr.2020.100220_bib42","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/MEG.0000000000000458","article-title":"Effects of probiotics (cultured Lactobacillus subtilis\/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study","volume":"27","author":"Han","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.jhepr.2020.100220_bib43","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.alcohol.2008.08.006","article-title":"Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study","volume":"42","author":"Kirpich","year":"2008","journal-title":"Alcohol"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100220_bib44","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhepr.2020.100220_bib45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12664-018-0859-4","article-title":"Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis","volume":"37","author":"Philips","year":"2018","journal-title":"Indian J Gastroenterol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555920301543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555920301543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:05:56Z","timestamp":1778904356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555920301543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2589555920301543"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2020.100220","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut dysbiosis as a driver in alcohol-induced liver injury","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2020.100220","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100220"}}